Relationship between Galectin-3 levels and severity of coronary artery disease in ST elevation myocardial infarction.

Background: Galectin-3 is a new biomarker assumed to reflect fibrogenesis and inflammation. We aimed to investigate the relation of Gal-3 with the severity of coronary artery disease in patients with ST elevation myocardial infarction.

Methods: The prospective study enrolled 62 patients with ST elevation myocardial infarction who underwent coronary angiography.